Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
803
mi
from 02139
Indianapolis, IN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Methodist Hospital, Indiana University Health Physicians
803
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
730
mi
from 02139
Hazard, KY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Kentucky Lung Clinic
730
mi
from 02139
Hazard, KY
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
357
mi
from 02139
Baltimore, MD
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Maryland Medical Center
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1
mi
from 02139
Boston, MA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2
mi
from 02139
Boston, MA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1116
mi
from 02139
Minneapolis, MN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Hennepin County Medical Center
1116
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1079
mi
from 02139
Rochester, MN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2366
mi
from 02139
Las Vegas, NV
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Sunrise Hospital/eStudySite
2366
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
179
mi
from 02139
Englewood, NJ
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Englewood Hospital and Medical Center
179
mi
from 02139
Englewood, NJ
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
216
mi
from 02139
New Brunswick, NJ
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Rutgers Robert Wood Johnson Medical Center
216
mi
from 02139
New Brunswick, NJ
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
176
mi
from 02139
Bronx, NY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Montefiore Medical Center
176
mi
from 02139
Bronx, NY
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
601
mi
from 02139
Durham, NC
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
635
mi
from 02139
Greensboro, NC
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Moses Cone Health
635
mi
from 02139
Greensboro, NC
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
544
mi
from 02139
Cleveland, OH
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Cleveland Clinic Foundation
544
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
639
mi
from 02139
Columbus, OH
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Riverside Methodist Hospital
639
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1489
mi
from 02139
Oklahoma City, OK
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Oklahoma Medical Center
1489
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
253
mi
from 02139
Allentown, PA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Lehigh Valley Health Network
253
mi
from 02139
Allentown, PA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
270
mi
from 02139
Philadelphia, PA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Univ of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
477
mi
from 02139
Pittsburgh, PA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Pittsburgh Medical Center
477
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
915
mi
from 02139
Chattanooga, TN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Erlanger Hospital
915
mi
from 02139
Chattanooga, TN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
915
mi
from 02139
Chattanooga, TN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Memorial Hospital
915
mi
from 02139
Chattanooga, TN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1610
mi
from 02139
Dallas, TX
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Baylor University
1610
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1763
mi
from 02139
San Antonio, TX
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
U.S. Army Military Medical Center
1763
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
402
mi
from 02139
Falls Church, VA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Inova Fairfax Hospital
402
mi
from 02139
Falls Church, VA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
472
mi
from 02139
Richmond, VA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
VCU Medical Center
472
mi
from 02139
Richmond, VA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1235
mi
from 02139
Mobile, AL
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Pulmonary Associates of Mobile, P.C.
1235
mi
from 02139
Mobile, AL
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2279
mi
from 02139
Phoenix, AZ
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Mayo Clinic
2279
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2538
mi
from 02139
Loma Linda, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Loma Linda University Medical Center
2538
mi
from 02139
Loma Linda, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2588
mi
from 02139
Los Angeles, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Keck Hospital of USC
2588
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2586
mi
from 02139
Los Angeles, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Los Angeles County/University of Southern California Medical Center
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2576
mi
from 02139
Orange, CA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of California, Irvine Medical Center
2576
mi
from 02139
Orange, CA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
934
mi
from 02139
Atlanta, GA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Emory University
934
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
821
mi
from 02139
Louisville, KY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Louisville
821
mi
from 02139
Louisville, KY
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2
mi
from 02139
Boston, MA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Beth Israel Deaconess Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
610
mi
from 02139
Detroit, MI
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Henry Ford Hospital
610
mi
from 02139
Detroit, MI
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
176
mi
from 02139
Bronx, NY
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Montefiore Medical Center-Weiler Division
176
mi
from 02139
Bronx, NY
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
606
mi
from 02139
Durham, NC
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Duke Regional Hospital
606
mi
from 02139
Durham, NC
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
635
mi
from 02139
Greensboro, NC
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Wesley Long Hospital
635
mi
from 02139
Greensboro, NC
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
736
mi
from 02139
Cincinnati, OH
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
University of Cincinnati Medical Center
736
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
547
mi
from 02139
Cleveland, OH
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Cleveland Clinic - Fairview Hospital
547
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
2530
mi
from 02139
Portland, OR
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Oregon Health and Sciences University
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
299
mi
from 02139
Danville, PA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Geisinger Medical Center
299
mi
from 02139
Danville, PA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
268
mi
from 02139
Philadelphia, PA
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Penn Presbyterian Medical Center
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1574
mi
from 02139
Fort Worth, TX
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
John Peter Smith Hospital - JPS Health Network
1574
mi
from 02139
Fort Worth, TX
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1110
mi
from 02139
Saint Paul, MN
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
St Paul Regions Hospital
1110
mi
from 02139
Saint Paul, MN
Click here to add this to my saved trials
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated:  2/27/2018
1036
mi
from 02139
Saint Louis, MO
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)
Status: Enrolling
Updated: 2/27/2018
Saint Louis University
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
862
mi
from 02139
Hinsdale, IL
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Adventist Midwest Health
862
mi
from 02139
Hinsdale, IL
Click here to add this to my saved trials
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
268
mi
from 02139
Philadelphia, PA
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Albert Einstein Medical Center
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
479
mi
from 02139
Pittsburgh, PA
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Allegheny General Hospital
479
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated:  2/28/2018
643
mi
from 02139
Ann Arbor, MI
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
Status: Enrolling
Updated: 2/28/2018
Ann Arbor Veteran's Administration Health System
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials